Oxford’s vaccine won’t be available in US until mid-2021 if FDA waits for trial end

Oxford’s vaccine won’t be available in US until mid-2021 if FDA waits for trial end

Jenner Institute Director Adrian Hill, who oversees the Oxford-AstraZeneca COVID-19 vaccine research and development, told NBC News that if the US Food and Drug Administration waits for the end of their vaccine trial, the vaccine would not be available in the US until “the middle of next year.”
“That’s too late to take the value of this vaccine, which is effective, available at large scale and easily deployed,” he said in remarks tweeted by NBC News on Wednesday.
Source From : Times Of India

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *